Health and Medical Research News
Postpartum depression (PPD) affects millions of new parents—but a new oral medication may offer faster relief. This breakthrough therapy showed faster results than traditional antidepressants, with many participants seeing improvements within just 15 days. While it's not a cure-all, zuranolone could
FDA
For Immediate Release: September 10, 2025Despite recent declines, opioids remain commonly prescribed to about 1 in 5 U.S. adults who live with chronic pain as effective alternatives are limited. As part of its broader strategy to address the opioid crisis, the U.S. Food and Drug Administration today issued
Diabetes
What Did the Research Discover? This study explored whether stopping metformin therapy—particularly for reasons unrelated to kidney dysfunction—was linked to an increased risk of developing dementia. Researchers analyzed data from Kaiser Permanente Northern California, following over 41,000 metformin users for up to 24 years. The findings revealed
Health and Medical Research News
A new 2024 study in Frontiers in Oncology looked at sacituzumab govitecan, a targeted therapy for triple-negative breast cancer (TNBC)—a fast-growing cancer with fewer treatment options. Already FDA-approved, this drug continues to show promising results, even in real-world settings, for women who’v
2024 Approvals
What is the name of the drug and what does it do? Miplyffa (pronounced MYE-pli-fah), generic name arimoclomol, is a medication used to treat neurological symptoms of Niemann-Pick disease type C (NPC). NPC is a rare genetic disorder that affects the body’s ability to process cholesterol and other fats,
Health and Medical Research News
How close are we to finding better treatments for Alzheimer’s disease? A 2024 review by Cummings and colleagues in Alzheimer’s & Dementia: Translational Research & Clinical Interventions breaks down the current global Alzheimer’s drug pipeline—revealing where the most promising therapies stand and w
FDA
For Immediate Release: September 05, 2025The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the U.S. market. This is part of the agency’s decisive steps
2024 Approvals
What is it prescribed for? ANKTIVA is indicated with Bacillus Calmette-Guérin (BCG) for the treatment of adult patients with BCGunresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. What is the name of the drug and what does it do? Anktiva (pronounced ank-TEE-vah)
Health and Medical Research News
Can routine blood tests help detect cancer earlier in people with abdominal pain or bloating? A new 2024 study in PLOS Medicine suggests they can. Researchers analyzed data from nearly half a million patients to find out which common lab results may signal hidden cancer risk—especially in older adul
2024 Approvals
What is it prescribed for? DUVYZAT is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. What is the name of the drug and what does it do? Duvyzat (pronounced doo-VY-zat), (generic name: givinostat), is a medication indicated
Trending News
Can vitamin D help protect children from long COVID? A 2025 study published in Frontiers in Pediatrics followed children hospitalized with COVID-19 and found a strong link between low vitamin D levels and an increased risk of long-lasting symptoms like fatigue, memory issues, and muscle pain. Subscr
Cancer
Breast cancer is not all the same. Some types are harder to treat than others. One of the toughest forms is called triple-negative breast cancer. A new medicine, sacituzumab govitecan, offers hope for patients whose cancer has spread and stopped responding to other treatments. What is Triple-Negative Breast Cancer? Triple-negative